A profile on the CardioMEMS HF system in the management of patients with early stages of heart failure: an update
暂无分享,去创建一个
G. Moukarbel | S. Khouri | M. Patel | R. Vyas
[1] Akshay S. Desai,et al. Sustained Reduction in Pulmonary Artery Pressures and Hospitalizations During 2 Years of Ambulatory Monitoring. , 2022, Journal of cardiac failure.
[2] Akshay S. Desai,et al. Hemodynamically-Guided Management of Heart Failure Across the Ejection Fraction Spectrum: The GUIDE-HF Trial. , 2022, JACC. Heart failure.
[3] B. Assmus,et al. Safety and efficacy of a wireless pulmonary artery pressure sensor: primary endpoint results of the SIRONA 2 clinical trial , 2022, ESC heart failure.
[4] Dave L Dixon,et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. , 2022, Journal of cardiac failure.
[5] F. Crea,et al. The V-LAP System for Remote Left Atrial Pressure Monitoring of Patients with Heart Failure: Remote Left Atrial Pressure Monitoring. , 2022, Journal of cardiac failure.
[6] Akshay S. Desai,et al. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial , 2021, The Lancet.
[7] S. Pedersen,et al. Effect of remote monitoring on clinical outcomes in European heart failure patients with an implantable cardioverter-defibrillator: secondary results of the REMOTE-CIED randomized trial , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[8] Akshay S. Desai,et al. Response by Shavelle et al to Letters Regarding Article, "Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval Study". , 2021, Circulation. Heart failure.
[9] J. Brachmann,et al. Pulmonary artery pressure‐guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS‐HF) , 2020, European journal of heart failure.
[10] G. Moukarbel,et al. CardioMEMSTM System in the Daily Management of Heart Failure: Review of Current Data and Technique of Implantation , 2020, Expert review of medical devices.
[11] W. Wijns,et al. Digital health care solution for proactive heart failure management with the Cordella Heart Failure System: results of the SIRONA first‐in‐human study , 2020, European journal of heart failure.
[12] Francesca N. Delling,et al. Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association , 2020, Circulation.
[13] J. Denollet,et al. Effect of remote monitoring on patient-reported outcomes in European heart failure patients with an implantable cardioverter-defibrillator: primary results of the REMOTE-CIED randomized trial. , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[14] L. Klein,et al. Internal Jugular Vein as Alternative Access for Implantation of a Wireless Pulmonary Artery Pressure Sensor. , 2019, Circulation. Heart failure.
[15] Sinan Sarsam,et al. CardioMems® device implantation reduces repeat hospitalizations in heart failure patients: A single center experience , 2019, JRSM cardiovascular disease.
[16] Nir Uriel,et al. Changes in pulmonary artery pressure before and after left ventricular assist device implantation in patients utilizing remote haemodynamic monitoring , 2018, ESC heart failure.
[17] Z. Khan,et al. Validating Left Ventricular Filling Pressure Measurements in Patients with Congestive Heart Failure: CardioMEMS™ Pulmonary Arterial Diastolic Pressure versus Left Atrial Pressure Measurement by Transthoracic Echocardiography , 2018, Cardiology research and practice.
[18] Sinan Sarsam,et al. Impact of CardioMEMS device placement on lifestyle modifications: a “pseudo-placebo” effect beyond the expected? , 2018, The Journal of international medical research.
[19] G. Moukarbel,et al. Patient Factors But Not the Use of Novel Anticoagulants or Warfarin Are Associated With Internal Jugular Vein Access-Site Hematoma After Right Heart Catheterization. , 2017, The Journal of invasive cardiology.
[20] M. Vaduganathan,et al. Postmarketing Adverse Events Related to the CardioMEMS HF System , 2017, JAMA cardiology.
[21] L. Stevenson,et al. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction. , 2017, Journal of the American College of Cardiology.
[22] L. Klein. (Re)Discovering the Neurohormonal and Hemodynamic Duality of Heart Failure. , 2017, Journal of the American College of Cardiology.
[23] D. Feldman,et al. The Utility of a Wireless Implantable Hemodynamic Monitoring System in Patients Requiring Mechanical Circulatory Support , 2017, ASAIO journal.
[24] L. Hűbbert,et al. Left Atrial Pressure Monitoring With an Implantable Wireless Pressure Sensor After Implantation of a Left Ventricular Assist Device , 2017, ASAIO journal.
[25] J. Morgan,et al. Remote management of heart failure using implantable electronic devices , 2017, European heart journal.
[26] Akshay S. Desai,et al. Ambulatory Hemodynamic Monitoring Reduces Heart Failure Hospitalizations in "Real-World" Clinical Practice. , 2017, Journal of the American College of Cardiology.
[27] Gerasimos S Filippatos,et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Journal of cardiac failure.
[28] Michael Illovsky,et al. Ambulatory Heart Failure Monitoring: A Systemic Review , 2017, Cureus.
[29] R. Jermyn,et al. Hemodynamic‐guided heart‐failure management using a wireless implantable sensor: Infrastructure, methods, and results in a community heart failure disease‐management program , 2017, Clinical cardiology.
[30] William T. Abraham,et al. Impact of Practice-Based Management of Pulmonary Artery Pressures in 2000 Patients Implanted With the CardioMEMS Sensor , 2017, Circulation.
[31] W. Aronow,et al. Ambulatory pulmonary artery pressure monitoring in advanced heart failure patients , 2017, World journal of cardiology.
[32] Akshay S. Desai,et al. Pulmonary Artery Pressure–Guided Heart Failure Management Reduces 30-Day Readmissions , 2016, Circulation. Heart failure.
[33] Michael Böhm,et al. Fluid status telemedicine alerts for heart failure: a randomized controlled trial. , 2016, European heart journal.
[34] L. Stevenson,et al. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial , 2016, The Lancet.
[35] Robert L Kormos,et al. Seventh INTERMACS annual report: 15,000 patients and counting. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[36] Jagmeet P. Singh,et al. Rationale and Design of the Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study (LAPTOP-HF). , 2015, Journal of cardiac failure.
[37] R. Benza,et al. Limitations of right heart catheterization in the diagnosis and risk stratification of patients with pulmonary hypertension related to left heart disease: insights from a wireless pulmonary artery pressure monitoring system. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[38] R. Benza,et al. Pulmonary hypertension related to left heart disease: insight from a wireless implantable hemodynamic monitor. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[39] William T. Abraham,et al. Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure With Preserved Ejection Fraction , 2014, Circulation. Heart failure.
[40] G. Hindricks,et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial , 2014, The Lancet.
[41] Naoki Sato,et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. , 2014, Journal of the American College of Cardiology.
[42] M. Guglin,et al. Patient selection for ventricular assist devices: a moving target. , 2013, Journal of the American College of Cardiology.
[43] M. Gheorghiade,et al. The worst symptom as defined by patients during heart failure hospitalization: implications for response to therapy. , 2012, Journal of cardiac failure.
[44] L. Stevenson,et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.
[45] D. Mancini,et al. Selection of Cardiac Transplantation Candidates in 2010 , 2010, Circulation.
[46] William T. Abraham,et al. Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure , 2010, Circulation.
[47] P. Adamson,et al. Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: New insights from continuous monitoring devices , 2009, Current heart failure reports.
[48] G. Navis,et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. , 2009, Journal of the American College of Cardiology.
[49] M. Zile,et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. , 2008, Journal of the American College of Cardiology.
[50] R. Bourge,et al. Comparison of a radiofrequency-based wireless pressure sensor to swan-ganz catheter and echocardiography for ambulatory assessment of pulmonary artery pressure in heart failure. , 2007, Journal of the American College of Cardiology.
[51] Javed Butler,et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. , 2007, Journal of the American College of Cardiology.
[52] Z. Jing,et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. , 2006, Journal of the American College of Cardiology.
[53] Monica R. Shah,et al. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness The ESCAPE Trial , 2005 .
[54] R. Hershberger,et al. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. , 2003, Journal of cardiac failure.
[55] M. Zile,et al. Intracardiac Pressures Measured Using an Implantable Hemodynamic Monitor: Relationship to Mortality in Patients With Chronic Heart Failure. , 2017, Circulation. Heart failure.
[56] G. Fonarow,et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Circulation.
[57] G. Fonarow,et al. The Prevention of Hospital Readmissions in Heart Failure. , 2016, Progress in cardiovascular diseases.